This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Apr 5;361(9364):1144-5.

doi: 10.1016/s0140-6736(03)12977-7.

What are the odds at ASCOT today?

Lars H Lindholm¹, Ola Samuelsson; ASCOT

Affiliations

PMID: 12686031
DOI: 10.1016/s0140-6736(03)12977-7

Comment

What are the odds at ASCOT today?

Lars H Lindholm et al. Lancet. 2003.

. 2003 Apr 5;361(9364):1144-5.

doi: 10.1016/s0140-6736(03)12977-7.

Authors

Lars H Lindholm¹, Ola Samuelsson; ASCOT

Affiliation

¹ Department of Public Health and Clinical Medicine, Umeå University, SE 901 85, Umeå, Sweden. larsh.lindholm@fammed.umu.se <larsh.lindholm@fammed.umu.se>

PMID: 12686031
DOI: 10.1016/s0140-6736(03)12977-7

No abstract available

PubMed Disclaimer

Comment in

ASCOT-LLA: questions about the benefits of atorvastatin.
Devroey D, Ginst LV. Devroey D, et al. Lancet. 2003 Jun 7;361(9373):1985-6; author reply 1986-7. doi: 10.1016/s0140-6736(03)13558-1. Lancet. 2003. PMID: 12801760 No abstract available.
ASCOT-LLA: questions about the benefits of atorvastatin.
Killestein J. Killestein J. Lancet. 2003 Jun 7;361(9373):1986; author reply 1986-7. doi: 10.1016/S0140-6736(03)13560-X. Lancet. 2003. PMID: 12801762 No abstract available.
ASCOT-LLA: questions about the benefits of atorvastatin.
Trewby P. Trewby P. Lancet. 2003 Jun 7;361(9373):1987. doi: 10.1016/S0140-6736(03)13562-3. Lancet. 2003. PMID: 12801764 No abstract available.
ASCOT-LLA: questions about the benefits of atorvastatin.
Drummond GA. Drummond GA. Lancet. 2003 Jun 7;361(9373):1987-8. doi: 10.1016/s0140-6736(03)13563-5. Lancet. 2003. PMID: 12801765 No abstract available.

Comment on

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Sever PS, et al. Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0. Lancet. 2003. PMID: 12686036 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science